Decker WW, Campbell RL, Manivannan V, Luke A, St Sauver JL, Weaver A, Bellolio MF, Bergstralh EJ, Stead LG, Li JT. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester epidemiology project. J Allergy Clin Immunol. 2008;122(6):1161–5.
Article
Google Scholar
Sheikh A, Hippisley-Cox J, Newton J, Fenty J. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med. 2008;101(3):139–43.
Article
Google Scholar
Poulos LM, Waters AM, Correll PK, Loblay RH, Marks GB. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993–1994 to 2004–2005. J Allergy Clin Immunol. 2007;120(4):878–84.
Article
Google Scholar
Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy. 2005;60(4):443–51.
Article
CAS
Google Scholar
Worm M. Epidemiology of anaphylaxis. Chem Immunol Allergy. 2010;95:12–21.
Article
Google Scholar
Przybilla BRF, Walker A, Raewer H, Aberer W, Bauer C, Berdel D, Biedermann T, Brockow K, Forster J, Fuchs T, Hamelmann E, Jakob T, Jarisch R, Merk H, Mueller U, Ott H, Sitter W, Urbanek R, Wedi B. Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergists (ÄDA), the Society for Pediatric Allergology and Environmental Medicine (GPA), the German Dermatological Society (DDG) and the German Society for Pediatric and Adolescent Medicine (DGKJ) in collaboration with the Austrian Society of Allergology and Immunology (ÖGAI) and the Swiss Society of Allergology and Immunology (SGAI). Diagnosis and therapy of bee and wasp venom allergy. Allergo J. 2011;20:318–39.
Article
Google Scholar
Pumphrey RS. Fatal posture in anaphylactic shock. J Allergy Clin Immunol. 2003;112(2):451–2.
Article
Google Scholar
Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;1(8009):466–9.
Article
CAS
Google Scholar
Confino-Cohen R, Rosman Y, Goldberg A. Rush venom Immunotherapy in children. J Allergy Clin Immunol Pract. 2017;5(3):799–803.
Article
Google Scholar
Golden DB, Demain J, Freeman T, Graft D, Tankersley M, Tracy J, Blessing-Moore J, Bernstein D, Dinakar C, Greenhawt M, et al. Stinging insect hypersensitivity: a practice parameter update 2016. Ann Allergy Asthma Immunol. 2017;118(1):28–54.
Article
Google Scholar
Stritzke AI, Eng PA. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom. Clin Exp Allergy. 2013;43(8):950–5.
Article
CAS
Google Scholar
Gür Çetinkaya P, Esenboğa S, Uysal Soyer Ö, Tuncer A, Şekerel BE, Şahiner ÜM. Subcutaneous venom immunotherapy in children: efficacy and safety. Ann Allergy Asthma Immunol. 2018;120(4):424–8.
Article
Google Scholar
Ruëff F, Przybilla B. Venom immunotherapy. Side effects and efficacy of treatment. Hautarzt. 2008;59(3):200–5.
Article
Google Scholar
Ragusa FV, Passalacqua G, Gambardella R, Campanari S, Barbieri MM, Scordamaglia A, Canonica GW. Nonfatal systemic reactions to subcutaneous immunotherapy: a 10-year experience. J Investig Allergol Clin Immunol. 1997;7(3):151–4.
CAS
PubMed
Google Scholar
Laurent J, Smiejan JM, Bloch-Morot E, Herman D. Safety of Hymenoptera venom rush immunotherapy. Allergy. 1997;52(1):94–6.
Article
CAS
Google Scholar
Reimers A, Hari Y, Müller U. Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial. Allergy. 2000;55(5):484–8.
Article
CAS
Google Scholar
Stoevesandt J, Hosp C, Kerstan A, Trautmann A. Safety of 100 µg venom immunotherapy rush protocols in children compared to adults. Allergy Asthma Clin Immunol. 2017;13:32.
Article
Google Scholar
Incorvaia C, Frati F, Dell’Albani I, Robino A, Cattaneo E, Mauro M, David M, Qualizza R, Pastorello E. Safety of Hymenoptera venom immunotherapy: a systematic review. Expert Opin Pharmacother. 2011;12(16):2527–32.
Article
CAS
Google Scholar
Ruëff F, Przybilla B. Ultrarush immunotherapy in patients with Hymenoptera venom allergy. J Allergy Clin Immunol. 2001;107(5):928–9.
Article
Google Scholar
Sturm GJ, Varga EM, Roberts G, Mosbech H, Bilo MB, Akdis CA, Antolin-Amerigo D, Cichocka-Jarosz E, Gawlik R, Jakob T, et al. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy. Allergy. 2018;73(4):744–64.
Article
CAS
Google Scholar
Niedoszytko M, de Monchy J, van Doormaal JJ, Jassem E, Oude Elberink JN. Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy. Allergy. 2009;64(9):1237–45.
Article
CAS
Google Scholar
Haeberli G, Brönnimann M, Hunziker T, Müller U. Elevated basal serum tryptase and Hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy. 2003;33(9):1216–20.
Article
CAS
Google Scholar
Ruiz B, Serrano P, Verdú M, Moreno C. Sensitization to Api m 1, Api m 2, and Api m 4: association with safety of bee venom immunotherapy. Ann Allergy Asthma Immunol. 2015;114(4):350–2.
Article
Google Scholar
Korošec P, Žiberna K, Šilar M, Dežman M, Čelesnik Smodiš N, Rijavec M, Kopač P, Eržen R, Lalek N, Bajrović N, et al. Immunological and clinical factors associated with adverse systemic reactions during the build-up phase of honeybee venom immunotherapy. Clin Exp Allergy. 2015;45(10):1579–89.
Article
Google Scholar
Galera C, Soohun N, Zankar N, Caimmi S, Gallen C, Demoly P. Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab. J Investig Allergol Clin Immunol. 2009;19(3):225–9.
CAS
PubMed
Google Scholar
Lockey RF, Turkeltaub PC, Olive ES, Hubbard JM, Baird-Warren IA, Bukantz SC. The Hymenoptera venom study. III: safety of venom immunotherapy. J Allergy Clin Immunol. 1990;86(5):775–80.
Article
CAS
Google Scholar
Hoffman DR, Jacobson RS. Allergens in Hymenoptera venom XII: how much protein is in a sting? Ann Allergy. 1984;52(4):276–8.
CAS
PubMed
Google Scholar
Blank S, Etzold S, Darsow U, Schiener M, Eberlein B, Russkamp D, Wolf S, Graessel A, Biedermann T, Ollert M, Schmidt-Weber CB. Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honeybee venom allergy. Hum Vaccines Immunother. 2017;3(10):2482–9.
Article
Google Scholar